Novotech Recognized as Top 10 CRO in CenterWatch Global Site Relationship Benchmarking Report Feb 09, 2022 15:00 HKT/SGT Read More
Avance Clinical Announces Major PE Investment for US Expansion at Biotech Showcase 2022 Jan 18, 2022 13:00 HKT/SGT Read More
Apollomics Inc. to Host Virtual Investor Events on Wednesday, January 26, 2022 and Thursday, January 27, 2022 Jan 12, 2022 09:25 HKT/SGT Read More
B-cell lymphoma clinical trials now open on the TrialWire Platform Jan 05, 2022 17:10 HKT/SGT Read More
Apollomics Inc. Announces CEO Guo-Liang Yu, PhD Appointed as Chairman of the Board for the BayHelix Group Jan 04, 2022 10:10 HKT/SGT Read More
Olympus Selected for Inclusion in Dow Jones Sustainability World Index (DJSI World) Dec 02, 2021 14:00 HKT/SGT Read More
Transgene and NEC Announce Positive Preliminary Data from Phase I Studies of TG4050, a Novel Individualized Neoantigen Cancer Vaccine Nov 23, 2021 10:14 HKT/SGT Read More
冠科美博(Apollomics)Uproleselan 注射液(APL-106)用于治疗复发或难治性急性髓系白血病的中国 III 期临床试验第一例受试者成功入组 Nov 22, 2021 10:42 HKT/SGT Read More
冠科美博(Apollomics)Uproleselan 注射液(APL-106)用於治療復發或難治性急性髓系白血病的中國 III 期臨床試驗第一例受試者成功入組 Nov 22, 2021 10:41 HKT/SGT Read More
Apollomics Inc. Doses First Patient in Phase 3 Clinical Trial with APL-106 (Uproleselan Injection) in Chinese Patients with Relapsed/Refractory Acute Myeloid Leukemia Nov 22, 2021 10:40 HKT/SGT Read More
Olympus Launches Venture Capital Fund to Strengthen Medtech Leadership Nov 12, 2021 07:30 HKT/SGT Read More